Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma

  • PDF / 530,135 Bytes
  • 2 Pages / 595.276 x 790.866 pts Page_size
  • 76 Downloads / 241 Views

DOWNLOAD

REPORT


CORRECTION

Correction to: Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib‑Treated Hepatocellular Carcinoma Giulia Orsi1 · Francesco Tovoli2,3 · Vincenzo Dadduzio4 · Caterina Vivaldi5,6 · Oronzo Brunetti7 · Luca Ielasi2,3 · Fabio Conti8 · Giulia Rovesti1 · Laura Gramantieri9 · Mario Domenico Rizzato4,10 · Irene Pecora5 · Antonella Argentiero7 · Federica Teglia2,3 · Sara Lonardi4 · Francesca Salani5 · Alessandro Granito2,3 · Vittorina Zagonel4 · Giorgia Marisi11 · Giuseppe Cabibbo12 · Francesco Giuseppe Foschi8 · Francesca Benevento2 · Alessandro Cucchetti2 · Fabio Piscaglia2,3 · Stefano Cascinu13,14 · Mario Scartozzi15 · Andrea Casadei‑Gardini13,14

© Springer Nature Switzerland AG 2020

Correction to: Targeted Oncology https​://doi.org/10.1007/s1152​3-020-00757​-3

An Online First version of this article was made available online at https​://link.sprin​ger.com/artic​le/10.1007/s1152​ 3-020-00757​-3 on 12 October 2020. Errors were subsequently identified in the article, and the following corrections should be noted. Page 1 and 13: The listing of the author names and affiliations, which previously read: “Giulia ­Orsi1, Francesco ­Tovoli2,3, Vincenzo ­Dadduzio4, Caterina ­Vivaldi5,6, Oronzo ­Brunetti7, Luca ­Ielasi2, Fabio The original article can be found online at https​://doi.org/10.1007/ s1152​3-020-00757​-3. * Andrea Casadei‑Gardini [email protected] 1



2



3



Department of Oncology and Hematology, Division of Oncology, University Hospital of Modena, Via del Pozzo 71, Modena, Italy

7



Medical Oncology Unit, IRCCS Istituto Tumori “Giovanni Paolo II”, Bari, Italy

8



Department of Internal Medicine, Faenza Hospital, AUSL Romagna, Faenza, Italy

9



Center for Applied Biomedical Research (CRBa), St. Orsola-Malpighi University Hospital, Bologna, Italy

Division of Internal Medicine, Azienda Ospedaliero-Universitaria di Bologna, via Albertoni 15, Bologna, Italy

Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy

11

Biosciences Laboratory, Istituto Scientifco Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola, Italy

12

Section of Gastroenterology and Hepatology, PROMISE, University of Palermo, Palermo, Italy

13

Vita-Salute San Rafaele University, Milan, Italy

14

Department of Medical Oncology, San Rafaele Scientifc Institute IRCCS, Milan, Italy

15

Department of Medical Oncology, University Hospital of Cagliari, Cagliari, Italy

5

Division of Medical Oncology 2, Pisa University Hospital, Pisa, Italy

6

Department of Translational Research and New Surgical and Medical Technologies, University of Pisa, Via Savi 6, 56126 Pisa, Italy



Department of Medical and Surgical Sciences - DIMEC, Alma Mater Studiorum-University of Bologna, Bologna, Italy

10

Medical Oncology Unit 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto, IRCCS, Padua, Italy



2

Department of Medical and Surgical Sciences‑DIMEC, Alma Mater Studiorum-University of Bologna, Bologna, Italy

4



­Conti8, Gi